14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
CEPO vs NAKA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Cantor Equity Partners I, Inc. Class A (CEPO) is the stronger overall head-to-head candidate over Kindly MD, Inc. (NAKA) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). CEPO carries a Unified Composite Score of 60.6/100 (BUY) at $10.83 (N/M Forward P/E, 0.0% operating margin), whereas NAKA carries 40.6/100 (SELL) at $3.44 (N/M Forward P/E, -103.4% operating margin).
Growth vs. Quality Trade-Off: CEPO earns the overall head-to-head edge with a stronger Unified Composite Score (60.6/100 BUY vs. NAKA 40.6/100 SELL) and -0.07β · 1% Vol risk profile, whereas NAKA leads top-line expansion (+8680.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CEPO trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 64.1); meanwhile NAKA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CEPO vs NAKA. Trailing 12-month operating profitability (CEPO 0.0% vs NAKA -103.4%) and valuation multiples (CEPO N/M vs NAKA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Capital Markets value chain with $75.0M market capitalization and -103.4% operating margin.
OpEx & R&D Reinvestment81.4% of Rev ($31M)
90D Engineering Disclosures0 Published
Investor FAQ CEPO vs NAKA Key Questions & Quantitative Answers
As of Nov 20, 2026, Cantor Equity Partners I, Inc. Class A (CEPO) is the stronger overall head-to-head candidate over Kindly MD, Inc. (NAKA) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). CEPO carries a Unified Composite Score of 60.6/100 (BUY) at $10.83 (N/M Forward P/E, 0.0% operating margin), whereas NAKA carries 40.6/100 (SELL) at $3.44 (N/M Forward P/E, -103.4% operating margin). Growth vs. Quality Trade-Off: CEPO earns the overall head-to-head edge with a stronger Unified Composite Score (60.6/100 BUY vs. NAKA 40.6/100 SELL) and -0.07β · 1% Vol risk profile, whereas NAKA leads top-line expansion (+8680.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CEPO trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 64.1); meanwhile NAKA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
NAKA leads the Growth & Scale pillar: CEPO posts +0.0% YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with NAKA at +8680.1% YoY revenue growth and +0.0% YoY earnings growth on $38M TTM revenue (-22.0% gross margin, -103.4% operating margin). On trailing 12-month operating scale, CEPO generates N/A in USD-normalized revenue versus $38M for NAKA. In operating R&D and SG&A reinvestment, CEPO deploys N/A (0 90-day corporate R&D disclosures) versus 81.4% of Rev ($31M) (0 disclosures) for NAKA.
NAKA screens cheaper on headline valuation multiples. CEPO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas NAKA trades at N/M Forward P/E, 0.2x Trailing P/E, N/M PEG, and 5.8x EV/Revenue (-118.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CEPO (68.0% ROE) versus NAKA (-343.3% ROE) capital efficiency.
In options market volatility and institutional positioning, CEPO carries 73.5% implied volatility (24th %ile, Compressed (<25th %ile)), a 0.59x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.07β · 1% Vol realized risk). By comparison, NAKA carries 158.2% implied volatility (29th %ile, Balanced (25th–60th %ile)), a 2.18x (Put-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (13.01β · 106% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.